Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Guanfacine for the Treatment of Spatial Neglect and Impaired Vigilance (GASNIV)

This study has been completed.
Sponsor:
Collaborator:
Wellcome Trust
Information provided by (Responsible Party):
Imperial College London
ClinicalTrials.gov Identifier:
NCT00955253
First received: August 7, 2009
Last updated: June 3, 2015
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)